文献速递临床微生物分子诊断

基于PCR的数字微流控与电化学检测系统直接从阳性血培养中快速鉴定15种真菌病原体的多中心评估

Multicenter Evaluation of a PCR-Based Digital Microfluidics and Electrochemical Detection System for the Rapid Identification of 15 Fungal Pathogens Directly from Positive Blood Cultures.
PubMed 文献 · J Clin Microbiol · 2020-04-23

本研究在多中心评估GenMark Dx ePlex BCID-FP panel直接从阳性血培养中检测15种真菌的性能。共检测866份临床样本和725份模拟样本,与常规方法比较。念珠菌属灵敏度97.1-100%、特异度99.8-100%,其他真菌靶标灵敏度96.2-100%、特异度99.9-100%。该panel可缩短鉴定时间并包含耳念珠菌。

要点

  • BCID-FP panel可快速鉴定15种真菌,念珠菌属灵敏度和特异度均高。
  • 在4/141份临床样本中额外检出常规方法未发现的念珠菌种。
  • 该panel包含高度耐药的耳念珠菌,有助于早期抗真菌干预。

核心结论

  • BCID-FP panel直接从阳性血培养中鉴定真菌病原体具有高灵敏度和特异度,可缩短报告时间。

研究设计与样本

  • 多中心临床研究,10个美国站点采集血培养样本,4个站点进行BCID-FP检测,与常规微生物学、PNA-FISH和MALDI-TOF MS比较,不一致结果用双向PCR/测序分析。
  • 共评估866份临床样本(120份回顾性、21份前瞻性)和725份模拟样本。

主要发现

  • 新型隐球菌和格特隐球菌灵敏度与特异度均为100%,镰刀菌属灵敏度98.6%、特异度100%,红酵母属灵敏度96.2%、特异度99.9%。
  • 141份临床样本中有4份BCID-FP正确鉴定出常规方法未检出的额外念珠菌种。

临床怎么用

  • BCID-FP可用于阳性血培养真菌的快速鉴定,缩短周转时间,可能允许更早开始抗真菌治疗。
  • 该panel包含耳念珠菌,对高度耐药真菌的早期识别和感染控制有潜在价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Routine identification of fungal pathogens from positive blood cultures by culture-based methods can be time-consuming, delaying treatment with appropriate antifungal agents. The GenMark Dx ePlex investigational use only blood culture identification fungal pathogen panel (BCID-FP) rapidly detects 15 fungal targets simultaneously in blood culture samples positive for fungi by Gram staining. We aimed to determine the performance of the BCID-FP in a multicenter clinical study. Blood culture samples collected at 10 United States sites and tested with BCID-FP at 4 sites were compared to the standard-of-care microbiological and biochemical techniques, fluorescence in situ hybridization using peptide nucleic acid probes (PNA-FISH) and matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS). Discrepant results were analyzed by bi-directional PCR/sequencing of residual blood culture samples. A total of 866 clinical samples, 120 retrospectively and 21 prospectively collected, along with 725 contrived samples were evaluated. Sensitivity and specificity of detection of Candida species (C. albicans, C. auris, C. dubliniensis, C. famata, C. glabrata, C. guilliermondii, C. kefyr, C. krusei, C. lusitaniae, C. parapsilosis, and C. tropicalis) ranged from 97.1 to 100% and 99.8 to 100%, respectively. For the other organism targets, sensitivity and specificity were as follows: 100% each for Cryptococcus neoformans and C. gattii, 98.6% and 100% for Fusarium spp., and 96.2% and 99.9% for Rhodotorula spp., respectively. In 4 of the 141 clinical samples, the BCID-FP panel correctly identified an additional Candida species, undetected by standard-of-care methods. The BCID-FP panel offers a faster turnaround time for identification of fungal pathogens in positive blood cultures that may allow for earlier antifungal interventions and includes C. auris, a highly multidrug-resistant fungus.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Zhang SX, Carroll KC, Lewis S, et al. Multicenter Evaluation of a PCR-Based Digital Microfluidics and Electrochemical Detection System for the Rapid Identification of 15 Fungal Pathogens Directly from Positive Blood Cultures. J Clin Microbiol. 2020. PMID: 32075904. doi:10.1128/JCM.02096-19

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。